Antibody‐Protein L Functionalized Microparticles for Detection of Surface Markers in Heterogeneous Colorectal Lesions

ABSTRACT Visualization of colorectal cancer (CRC) lesions is complicated by their location in the colon and tumor morphology. Reliance on a single surface biomarker for direct identification risks false negatives due to temporal changes and/or tumor heterogeneity. We developed a multiplexed system of complementary biomarker targets to capture a broader range of lesions with diverse temporal and/or phenotypic expression. We identified Mucin‐1 (MUC1) and epithelial cell adhesion molecule (EPCAM) as useful targeting pairs by phenotyping CRC subtypes in a standard tissue array and surveying CRC cell lines in 2D and 3D formats to confirm expression of these surface biomarkers. Through a “universal” approach using Antibody‐Protein L Microparticles (APL‐MPs), we functionalized microparticle surfaces with antibodies recognizing either MUC1 or EPCAM. We generated heterogeneous CRC tumoroids and orthotopic animal models, expressing both MUC1 and EPCAM, and demonstrated that: (1) APL‐MPs identified MUC1‐ and EPCAM‐positive tumoroids in proportion to antigen expression; (2) APL‐MPs detected CRC surface antigens on the luminal colon surface in vivo, and (3) concurrent targeting of multiple surface antigens enhanced detection sensitivity for heterogeneous CRC lesions. This approach supports broader applications of APL‐MPs for detecting heterogeneous cancer lesions and offers a promising strategy for accurate tumor visualization in complex environments.

Authors

Institutions

Publication Details

Journal
Advanced Healthcare Materials
Published
2026-11-14
DOI
https://doi.org/10.1002/adhm.71877
Primary Topic
Nanoplatforms for cancer theranostics
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Antibody‐Protein L Functionalized Microparticles for Detection of Surface Markers in Heterogeneous Colorectal Lesions

Niki Marie Zacharias, Ryan Armijo, Pratip K. Bhattacharya, Mary C. Farach‐Carson et al.
Advanced Healthcare Materials
Nanoplatforms for cancer theranostics
article

Antibody‐Protein L Functionalized Microparticles for Detection of Surface Markers in Heterogeneous Colorectal Lesions

Niki Marie Zacharias, Ryan Armijo, Pratip K. Bhattacharya, Mary C. Farach‐Carson, Daniel D. Carson, Daniel A. Harrington, Saleh Ramezani, Jennifer Sarah Davis, Muxin Wang, Abishai Dominic, Richard E. Wendt
article en

Abstract

ABSTRACT Visualization of colorectal cancer (CRC) lesions is complicated by their location in the colon and tumor morphology. Reliance on a single surface biomarker for direct identification risks false negatives due to temporal changes and/or tumor heterogeneity. We developed a multiplexed system of complementary biomarker targets to capture a broader range of lesions with diverse temporal and/or phenotypic expression. We identified Mucin‐1 (MUC1) and epithelial cell adhesion molecule (EPCAM) as useful targeting pairs by phenotyping CRC subtypes in a standard tissue array and surveying CRC cell lines in 2D and 3D formats to confirm expression of these surface biomarkers. Through a “universal” approach using Antibody‐Protein L Microparticles (APL‐MPs), we functionalized microparticle surfaces with antibodies recognizing either MUC1 or EPCAM. We generated heterogeneous CRC tumoroids and orthotopic animal models, expressing both MUC1 and EPCAM, and demonstrated that: (1) APL‐MPs identified MUC1‐ and EPCAM‐positive tumoroids in proportion to antigen expression; (2) APL‐MPs detected CRC surface antigens on the luminal colon surface in vivo, and (3) concurrent targeting of multiple surface antigens enhanced detection sensitivity for heterogeneous CRC lesions. This approach supports broader applications of APL‐MPs for detecting heterogeneous cancer lesions and offers a promising strategy for accurate tumor visualization in complex environments.

Advanced Healthcare Materials
The University of Texas MD Anderson Cancer Center (US), University of Kansas Medical Center (US), Rice University (US), The University of Texas Health Science Center at Houston (US)
U.S. Department of Defense, Cancer Prevention and Research Institute of Texas, University of Texas Health Science Center at Houston, University of Texas MD Anderson Cancer Center, National Institute of Biomedical Imaging and Bioengineering, U.S. National Library of Medicine
Good health and well-being
Nanoplatforms for cancer theranostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon